ABACUS and Goldman Sachs

The Meissner firm investigating potential claims by investors who were recommended the unsuitable sale by Securities America broker Randall Ray Talbott and other of Medical Capital Holdings
The Meissner Firm Investigating Bank of America Structured Products
Lehman Brothers “One Hundred Percent Protected” Principal Protected Notes (PPN)
The Morgan Keegan Bond Funds
Rhonda Breard and ING Financial
Wells Fargo Financial Investments and Sale of Market Linked Certificates of Deposits
Collateralized Debt Obligation Investigation
Provident Royalties Fraud/Ponzi Scheme
Citigroup’s ASTA and MAT Funds:
Oppenheimer Champion Income Fund:
Oppenheimer Core Bond Fund
The Aravali Fund
Preferred Financial Stocks
Td Ameritrade Reserve Yield Plus Fund
Shay Financial Services, Inc
ABACUS and Goldman Sachs

The Meissner firm is  investigating the sales practices and marketing of  CDO called ABACUS 2007 AC1 (“ABACUS 2007″) by Goldman Sachs. The SEC filed on April 16, 2010 charges against Goldman Sachs for making materially misleading statements and omissions in connection with [ABACUS 2007]”. The Complaint “Goldman Sachs failed to disclose to investors vital information about [ABACUS 2007], in particular the role that a major hedge fund played in the portfolio selection process and the fact that the hedge fund had taken a short position against [ABACUS 2007]”  The Sec alleged that Goldman allowed a client that was betting against the mortgage market to heavily influence which mortgage securities to include in an investment portfolio, while telling other investors that the securities were selected by an independent, objective third party.  Mr. Meissner was a commentator on Fox Business News Network when news broke on the scandal and is investigating the filing of claims related to such marketing practices of Goldman Sachs in relation to ABACUS. If you sustained substantial losses by investing in these funds contact the Meissner firm which is nationally known for its record win statistics in arbitration, for a free consultation.